cFGF23 gene therapy (Genethon)

N/A

Report date: 2025/01/26 17:52:51

Base Information

Drug NamecFGF23 gene therapy (Genethon)

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionFibroblast growth factor 23 antagonists

TargetsFibroblast growth factor 23

Therapy Area/IndicationsHypophosphatemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenethon

China Registration ClassN/A

Active CompaniesGenethon

Inactive CompaniesN/A

Active IndicationsHypophosphatemia

Inactive IndicationsN/A

ATC CodeN/A